Sabapathy, K <br/><br/>
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.  [electronic resource] 

 -  Current biology : CB  Feb 1999 
 - 116-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0960-9822 
<br/><br/><label>Standard No.: </label>10.1016/s0960-9822(99)80065-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Apoptosis<br/>B-Lymphocytes--immunology<br/>Dexamethasone--pharmacology<br/>Drug Resistance<br/>Gene Targeting<br/>Isoenzymes--deficiency<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinase 9<br/>Mitogen-Activated Protein Kinases<br/>Muromonab-CD3--pharmacology<br/>Protein Kinases--deficiency<br/>RNA Splicing<br/>T-Lymphocytes--cytology<br/>Ultraviolet Rays<br/>fas Receptor--immunology